Results 1 to 10 of about 40,494 (191)
The American Journal of Surgery, 1962 Since pheochromocytomas result in a curable form of hypertension, there should be an awareness of its diagnostic features. These include the following: paroxysmal hypertension, paroxysmal vasomotor phenomena, hypermetabolism with loss of weight or elevation of the basal metabolic rate, and “diabetes” with hyperglycemia and glycosuria.
V, VERTES, J, ANGELES, Y, KANTER
+7 more sources
A Narrative Review of Pheochromocytoma in VHL [PDF]
Journal of Kidney Cancer and VHLThis systematic review aims to investigate the clinical presentation, diagnostic methods, and management strategies for pheochromocytoma in patients with von Hippel-Lindau (VHL) disease, an autosomal dominant disorder that predisposes individuals to the
Danilo Coco, Silvana Leanza
doaj +3 more sources
Spontaneous adrenal pheochromocytoma rupture complicated by intraperitoneal hemorrhage and shock [PDF]
World Journal of Emergency Surgery, 2011 MEN2A is a hereditary syndrome characterized by medullary thyroid carcinoma, hyperparathyroidism, and pheochromocytoma. Classically patients with a pheochromocytoma initially present with the triad of paroxysmal headaches, palpitations, and diaphoresis ...
Kwasnik Edward +4 more
doaj +4 more sources
Frontiers in Endocrinology, 2022 BackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare syndrome that presents as medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
Yaohan Li +5 more
doaj +1 more source
Anesthesiology, 1978 Pheochromocytoma, a relatively rare (<0.05% of hypertensives), catecholamine‐secreting tumor, is almost always lethal unless recognized and appropriately treated. Clinical and biochemical manifestations are mainly caused by excess circulating catecholamines and hypertension.
and William M. Manger Md, Ray W. Gifford
openaire +3 more sources
IJU Case Reports, 2022 Introduction Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism.
Koshiro Nishimoto +11 more
doaj +1 more source
Endocrine Regulations, 2019 Abstract Pheochromocytomas are rare tumors originating in the adrenal medulla. They may be sporadic or in the context of a hereditary syndrome. A considerable number of pheochromocytomas carry germline or somatic gene mutations, which are inherited in the autosomal dominant way. All patients should undergo genetic testing.
Farrugia Frederick-Anthony +1 more
openaire +3 more sources
Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. [PDF]
PLoS ONE, 2013 Metastatic pheochromocytoma represents one of the major clinical challenges in the field of neuroendocrine oncology. Recent molecular characterization of pheochromocytoma suggests new treatment options with targeted therapies.
Alessio Giubellino +9 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectivePheochromocytoma is a rare catecholamine-producing neuroendocrine tumour originating from the chromaffin cells of the adrenal medulla or extra-adrenal paraganglia. However, there are few bibliometric studies on Pheochromocytoma.
Bi-ling Huang +17 more
doaj +1 more source
Pheochromocytoma with Takotsubo Syndrome and acute heart failure: a case report
World Journal of Surgical Oncology, 2022 Background Pheochromocytoma is a neuroendocrine tumor that can overproduce catecholamines. Heart failure and Takotsubo Syndrome (TTS) caused by excessive catecholamines are uncommon pheochromocytoma complications.
Lin Yang +3 more
doaj +1 more source